106 Treatment with CC-99282 enhances antitumor function of the anti-CD19 CAR T cell therapy lisocabtagene maraleucel (liso-cel)

• Susan Kim,
• Yue Jiang,
• Archana Brahmandam,
• Jim Qin,
• Brook Barajas,
• Soraya Carrancio,
• Leanne Peiser

Affiliations

Susan Kim

2 Heart Health, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia

Yue Jiang

Jiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Nanjing, China

Archana Brahmandam

Bristol Myers Squibb, Seattle, WA, USA

Jim Qin

Bristol Myers Squibb, Seattle, WA, USA

Brook Barajas

Bristol Myers Squibb, Seattle, WA, USA

Soraya Carrancio

Bristol Myers Squibb, Seattle, WA, USA

Leanne Peiser

Bristol Myers Squibb, Seattle, WA, USA